Isomorphic Labs raises a $2.1 billion Series B
On 12 May 2026 Isomorphic Labs announced a $2.1 billion Series B round led by Thrive Capital, money the company says will scale its business globally and push its drug candidate pipeline forward.
Total 1 · Clear filters